ArticleThe European respiratory journal2020
Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?
Article in The European respiratory journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- COVID-19 vaccination lowers SARS-CoV-2 infection risk independent of diabetes, cancer and smoking in SHIP-COVID cohort, Northern Germany.Scientific reports · 2025Article
- Protecting effects of smoking against COVID-19: a community-based retrospective cohort study in middle- and older-aged adults.Internal and emergency medicine · 2024Article
- Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study.BMC infectious diseases · 2024Article
- Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease Severity Among Adults in an Integrated Healthcare System in California.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- Electronic cigarette use and risk of COVID-19 among young adults without a history of cigarette smoking.Preventive medicine · 2022Article
- Cardiovascular manifestations secondary to COVID-19: A narrative review.Respiratory medicine and research · 2022Review
- Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile.BMC infectious diseases · 2022Article
- Nicotinic receptors as SARS-CoV-2 spike co-receptors?Medical hypotheses · 2022Article
- Multiple Neuroinvasive Pathways in COVID-19.Molecular neurobiology · 2021Review
- SARS-CoV-2 infection and smoking: What is the association? A brief review.Computational and structural biotechnology journal · 2021Review
- Tobacco use as a well-recognized cause of severe COVID-19 manifestations.Respiratory medicine · 2021Review
- Smoking Prevalence and COVID-19 in Europe.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020Article
Corrections and comments
- Commented on by
- Comment on
- Comment on
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.